[go: up one dir, main page]

NO20010219D0 - Polycykliske tiazolidin-2-yliden aminer, fremgangsmåte for deres fremstilling og deres anvendelse som legemiddel - Google Patents

Polycykliske tiazolidin-2-yliden aminer, fremgangsmåte for deres fremstilling og deres anvendelse som legemiddel

Info

Publication number
NO20010219D0
NO20010219D0 NO20010219A NO20010219A NO20010219D0 NO 20010219 D0 NO20010219 D0 NO 20010219D0 NO 20010219 A NO20010219 A NO 20010219A NO 20010219 A NO20010219 A NO 20010219A NO 20010219 D0 NO20010219 D0 NO 20010219D0
Authority
NO
Norway
Prior art keywords
ylidine
amines
drug
preparation
thiazolidin
Prior art date
Application number
NO20010219A
Other languages
English (en)
Other versions
NO318790B1 (no
NO20010219L (no
Inventor
Gerhard Jaehne
Karl Geisen
Hans Jochen Lang
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20010219D0 publication Critical patent/NO20010219D0/no
Publication of NO20010219L publication Critical patent/NO20010219L/no
Publication of NO318790B1 publication Critical patent/NO318790B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20010219A 1998-07-17 2001-01-12 Polycykliske tiazolidin-2-ylidenaminer, medikament innbefattende samme og anvendelse av samme for fremstilling av medikament NO318790B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19831878A DE19831878C2 (de) 1998-07-17 1998-07-17 Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/004644 WO2000004006A1 (de) 1998-07-17 1999-07-03 Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO20010219D0 true NO20010219D0 (no) 2001-01-12
NO20010219L NO20010219L (no) 2001-03-15
NO318790B1 NO318790B1 (no) 2005-05-09

Family

ID=7874197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010219A NO318790B1 (no) 1998-07-17 2001-01-12 Polycykliske tiazolidin-2-ylidenaminer, medikament innbefattende samme og anvendelse av samme for fremstilling av medikament

Country Status (25)

Country Link
US (1) US6159996A (no)
EP (1) EP1098891B1 (no)
JP (1) JP3541808B2 (no)
KR (1) KR20010083118A (no)
CN (1) CN1144797C (no)
AR (1) AR019925A1 (no)
AT (1) ATE301645T1 (no)
AU (1) AU767151B2 (no)
BR (1) BR9912151A (no)
CA (1) CA2337838A1 (no)
CL (1) CL2004000219A1 (no)
DE (2) DE19831878C2 (no)
DK (1) DK1098891T3 (no)
ES (1) ES2246089T3 (no)
HU (1) HUP0104942A3 (no)
ID (1) ID26985A (no)
IL (1) IL140767A (no)
NO (1) NO318790B1 (no)
NZ (1) NZ509395A (no)
PL (1) PL345619A1 (no)
PT (1) PT1098891E (no)
RU (1) RU2236405C2 (no)
TR (1) TR200100125T2 (no)
WO (1) WO2000004006A1 (no)
ZA (1) ZA200100279B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
HUP0203290A3 (en) * 1999-11-05 2004-12-28 Sanofi Aventis Deutschland Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
WO2001062747A1 (de) * 2000-02-26 2001-08-30 Aventis Pharma Deutschland Gmbh 8,8a-dihydro-indeno[1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7977532B2 (en) * 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US20080042557A1 (en) * 2004-07-09 2008-02-21 Taku Kato Process for Purification of Oligoanilines and Oligoanilines
EP1960343B1 (en) * 2005-11-08 2012-04-04 Laboratorios del Dr. Esteve S.A. Indene derivatives, their preparation and use as medicaments
TWI443102B (zh) * 2008-03-31 2014-07-01 Genentech Inc 苯并哌喃及苯并氧呯ｐｉ３ｋ抑制劑化合物及其使用方法
BR112013023330B8 (pt) 2011-03-16 2022-09-27 Mitsubishi Tanabe Pharma Corp Compostos de sulfonamida tendo atividade antagonista trpm8

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
IL140767A (en) 2005-12-18
BR9912151A (pt) 2001-04-10
AU767151B2 (en) 2003-10-30
TR200100125T2 (tr) 2001-05-21
EP1098891B1 (de) 2005-08-10
EP1098891A1 (de) 2001-05-16
HUP0104942A3 (en) 2003-12-29
DK1098891T3 (da) 2005-12-12
RU2236405C2 (ru) 2004-09-20
DE59912402D1 (de) 2005-09-15
ZA200100279B (en) 2001-08-07
ATE301645T1 (de) 2005-08-15
NO318790B1 (no) 2005-05-09
JP2002520404A (ja) 2002-07-09
DE19831878A1 (de) 2000-01-27
CA2337838A1 (en) 2000-01-27
AU5030899A (en) 2000-02-07
DE19831878C2 (de) 2001-05-17
PT1098891E (pt) 2005-11-30
JP3541808B2 (ja) 2004-07-14
WO2000004006A1 (de) 2000-01-27
CN1309653A (zh) 2001-08-22
CN1144797C (zh) 2004-04-07
CL2004000219A1 (es) 2005-04-22
AR019925A1 (es) 2002-03-27
NZ509395A (en) 2003-10-31
HUP0104942A2 (hu) 2002-04-29
KR20010083118A (ko) 2001-08-31
NO20010219L (no) 2001-03-15
ID26985A (id) 2001-02-22
IL140767A0 (en) 2002-02-10
ES2246089T3 (es) 2006-02-01
US6159996A (en) 2000-12-12
HK1038560A1 (en) 2002-03-22
PL345619A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
NO20025879D0 (no) Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1202733T3 (da) 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
NO20012058L (no) 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20021719D0 (no) 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
NO20002486D0 (no) Sykliske aminderivater og deres anvendelse som legemidler
DK0911340T3 (da) Substituerede isoquinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
NO20033726L (no) Xantin-derivater, fremstilling og anvendelse derav som et medikament
NO20020687L (no) 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO20011503L (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO20010219D0 (no) Polycykliske tiazolidin-2-yliden aminer, fremgangsmåte for deres fremstilling og deres anvendelse som legemiddel
NO20013900D0 (no) Epotilonderivater, fremgangsmate og anvendelse derav som legemiddel
NO20023146L (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
DK0903339T3 (da) Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
PT1341758E (pt) Coniosetina e seus derivados, processo para a sua preparacao e utilizacao dos mesmos